Evaluation of Late Postoperative Pulmonary Function Following Lobectomy in Patients With Tubercular and Non-tubercular Lung Diseases

结核性和非结核性肺病患者肺叶切除术后远期肺功能评估

阅读:1

Abstract

BACKGROUND: Pulmonary function testing, especially spirometry, is essential for assessing patients after pulmonary resection for tubercular and non-tubercular diseases. Tuberculosis (TB) remains a major cause of death globally, while other non-tubercular conditions such as lung abscess, bullous disease, and bronchiectasis also require lobectomy. This study aimed to compare late postoperative pulmonary function following lobectomy between TB and non-TB patients. METHODS: This cross-sectional study included 60 patients (30 TB, 30 non-TB) who underwent lobectomy at the National Institute of Diseases of the Chest and Hospital between January 2022 and June 2023. Pulmonary function was evaluated using spirometry, measuring forced vital capacity (FVC) and forced expiratory volume in one second (FEV(1)). The FEV(1)/FVC ratio was also calculated to assess the presence and severity of obstructive or restrictive lung patterns. Data were collected using a semi-structured questionnaire via face-to-face interviews. RESULTS: Among TB patients, 86.67% had postoperative forced expiratory volume in one second (FEV(1)) <2 L, compared to 60% in non-TB patients (p<0.05). Postoperative forced vital capacity (FVC) ≥2 L was found in 40% of TB and 43.33% of non-TB patients (p<0.05). Although FEV(1)/FVC improved in both groups, the difference was not statistically significant. Hospital stay, intraoperative bleeding, lobe involvement, and underlying disease showed significant differences between groups. CONCLUSION: Non-TB patients demonstrated better postoperative pulmonary function than TB patients. These findings may guide perioperative planning and help reduce complications following lobectomy.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。